High-quality and reproducible Next-Generation Sequencing (NGS) data are generated using validated, state-of-the-art sequencing platforms with stringent quality control. Our NGS workflows are customized to address specific genomic and transcriptomic research objectives, supported by expert scientific consultation. Advanced bioinformatics analysis enables robust data interpretation, including HLA typing, microsatellite instability (MSI) assessment, mutation rate analysis, and variant concordance.
Price | 599€+ |
Organism | Human |
Product Type | Next Generation Sequencing(NGS) analaysis services |
Tissue | – |
Disease | – |
Applications
Technology Service
Next-Generation Sequencing (NGS)
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Next-Generation Sequencing (NGS) is a rapid and efficient DNA sequencing technology used for analyzing multiple samples in bulk. Widely applied in genomics, transcriptomics, and personalized medicine, NGS offers fast and accurate results.
At Lambda Biologics, our team of specialists utilizes the latest analytical technologies and extensive experience to deliver results that closely align with researchers’ objectives. We are dedicated to providing rapid and accurate results tailored to our customers’ research needs.
Wes provides Whole Exome Sequencing (WES) to comprehensively identify genetic variations, particularly useful for diverse of cells and tissues and especially Organoid Quality Control. We ensure the accuracy, reliability, and suitability for various research applications.
With a combination of high-quality sequencing, flexible analysis, and human-relevant expertise, Lambda Biologics’ Next-Generation Sequencing (NGS) service supports reliable and insightful genomic research outcomes.
Contact us to discuss your project requirements and customized NGS solutions.
Next-Generation Sequencing (NGS) is a high-throughput sequencing technology that enables simultaneous analysis of millions of DNA or RNA fragments in a single experiment, providing comprehensive genomic and transcriptomic data.
Lambda Biologics provides flexible NGS services, including Whole Exome Sequencing (WES), targeted sequencing, and variant analysis. Bioinformatics workflows can be customized based on research objectives.
Yes. Standard data processing and quality control are included. Advanced bioinformatics analyses – such as variant annotation, HLA typing, MSI status, mutation rate, and variant concordance – are available upon request.
A standard workflow includes sample preparation and library construction, high-throughput sequencing, data processing and quality assessment, followed by bioinformatics analysis and reporting.
The service is suitable for genomic research, variant discovery, translational studies, drug discovery, and characterization of human-based in vitro models, including organoids.
